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Introduction
Cluster headache is marked by its circadian rhythmicity.
Episodic cluster periods start at the same time each year,
individual cluster headaches occur at the same time each day
and the duration of each cluster headache is almost the same
for every attack. These clinical features along with the hor-
monal alterations documented in cluster patients suggest a
role for the hypothalamus in cluster genesis. PET studies by
May et al. [1] showing hypothalamic activation during clus-
ter headache attacks solidified the notion of a hypothalamic
influence in cluster headache. The concept of the hypothala-
mus acting as a cluster headache generator has also been
entertained. However, not all cluster patients present in the
same manner and not all respond to the same medications,
suggesting that there must be atypical and even non-hypo-
thalamic forms of cluster headache. A patient is presented
who had no prior history of cluster headache but who began
to develop cluster attacks after receiving bilateral greater
occipital nerve (GON) blockade for chronic daily migraine.
The post-procedure headaches fit the IHS criteria for cluster
but had some irregularities including frequent side shifting
of pain, irregular duration and time of onset of attacks and
the ability of the patient to sit completely still during a
headache without any sense of agitation. This article will
suggest that some forms of cluster headache are not primar-
ily hypothalamic driven and that the GON may play a sig-
nificant role in cluster pathogenesis in some individuals.
Case report
A 54-year-old man with a long history of refractory chronic
migraine underwent bilateral GON blockade for persistent
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Abstract Cluster headache is
marked by its circadian rhythmicity
and the hypothalamus appears to
have a significant influence over
cluster pathogenesis. However, as
not all cluster patients present in
the same manner and not all
respond to the same combination of
medications, there is likely a non-
hypothalamic form of cluster
headache. A patient is presented
who began to develop cluster
headaches after receiving bilateral
greater occipital nerve (GON)
blockade. His headaches fit the IHS
criteria for cluster headache but had
some irregularities including fre-
quent side shifting of pain, irregular
duration and time of onset and the
ability of the patient to sit com-
pletely still during a headache with-
out any sense of agitation. This arti-
cle will suggest that some forms of
cluster headache are not primarily
hypothalamic influenced and that
the GON may play a significant
role in cluster pathogenesis in some
individuals.
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pain in his occipito-nuchal area. The GON block was com-
pleted after written consent utilising 9 cc of 1% lidocaine and
1 cc of 40 mg triamcinolone (5 cc applied to each side). He
tolerated the procedure without complications and for the
first four days had a decrease in his head and neck pain. On
day 5 he began to develop a new type of headache. Whereas
his typical daily pain was constant and bifrontal/bioccipito-
nuchal in location, the new headaches were only one-sided in
and around his eye, of severe intensity, lasting 30–90 min and
associated with eyelid ptosis, lacrimation and nasal rhinor-
rhoea. He denied any nausea, vomiting, photophobia or
phonophobia. The headaches occurred 2–4 times per day.
During a headache he remained completely still without any
sense of agitation. The headaches were always one-sided but
readily switched sides with every attack or every other attack
without a set pattern. For example, one day the headaches
would occur consecutively on the right side, right side and
left side and the next day only on the left side. The headaches
would also start at any time during the day with great irregu-
larity. One day they would take place at 9:30 am, 3:00 pm and
8:00 pm and the next day at 10:45 am and 3:45 pm. Headache
duration was also not constant although most headaches last-
ed from 30 to 75 min. The patient presented to the office dur-
ing a typical attack. He had unilateral eyelid ptosis, lacrima-
tion and rhinorrhoea but was able to sit completely still with-
out any sense of agitation even though the pain level was
severe. In regard to treatment the headaches readily and con-
sistently responded to oxygen therapy, normally alleviating
the pain within 10–15 min. Sumatriptan was never tried as
the patient had a history of cardiac ischaemia. A prednisone
taper provided some relief but did not stop the cycle. Bilateral
GON blockade was completed three weeks into the cycle of
headaches to try to stop them. It decreased the number of
attacks by one per day but did not completely shut off the
cycle. After one month on topiramate (dose 200 mg/day) the
frequency of headaches decreased and the patient started to
have some headache-free days. After three months the cycle
stopped and he has had no recurrence of this type of headache
with a one-year follow-up. The patient had a history of ciga-
rette smoking and ETOH abuse but had taken neither for
many years. There was no family history of cluster headache.
Prior to his transformation into chronic migraine he suffered
from episodic migraine headaches, which were not at all sim-
ilar to this new type of headache. Brain MRI and MRA of the
intracranial and extracranial carotid circulation, completed
after the onset of the cluster-like headaches, were normal.
Discussion
The presented patient developed cluster headaches after
GON blockade. The lack of rhythmicity of the
headaches, the frequent side shifting of attacks and the
ability to sit still during a headache are all qualities
uncharacteristic of “hypothalamic influenced cluster”.
The hypothalamus oversees an individual’s internal cir-
cadian clock thus a hypothalamic governed disorder will
present with fixed periodicity and rhythmicity as is seen
in primary cluster headache. The hypothalamus also
plays a role in locomotion in animals [2]. Hypothalamic
stimulation causes animals to become active and move
around, suggesting it is hypothalamic activation that
leads to the agitation and inability to sit still which is a
hallmark of cluster headache. The fixed location of
headache in cluster with little if any side-shifting during
or between cluster periods reflects that only one side of
the hypothalamus is activated during a cluster attack and
cluster period as represented by the ipsilateral only find-
ings on PET [1]. The presented patient did indeed have
cluster headache, but with irregular features. If this was
not hypothalamic-influenced cluster, what could be trig-
gering his cluster attacks?
In this patient the cluster headaches occurred after
GON blockade, thus questioning if the GON could be a
potential generator of cluster attacks. Anatomical and
clinical research data suggest that the GON can produce
pain in the typical location of cluster and the autonomic
symptoms noted in cluster headache. Sensory neurons in
the trigeminocervical complex receive ipsilateral and con-
tralateral input from the GON [3]. Electrophysiological
studies suggest that there is a convergence of dural and
cervical afferents in the GON and then onto the
trigeminocervical complex in humans [4]. GON stimula-
tion has been shown to cause frontal head pain in humans
[5]. In addition, Piovesan et al. [5] documented a patient
who after GON stimulation developed not only pain in the
head area innervated by the ophthalmic division of the
trigeminal nerve but also ipsilateral conjunctival injection
and lacrimation. Thus it appears that short-lasting GON
stimulation is able to produce a cluster-like headache. The
method by which the GON was stimulated or activated in
this patient after a blockade procedure can only be
hypothesised. It is well recognised that some patients who
undergo nerve blockade for pain control develop a wors-
ening of their pain when the blockade wears off. This sug-
gests that once the nerve is unblocked it becomes hyper-
excited or stimulated. The block procedure itself (needle
insertion) could also have activated the GON. Recently
the author completed a GON block on a cluster patient
who began to develop a cluster headache during an office
visit. Almost immediately after needle insertion the clus-
ter headache worsened for several minutes then it com-
pletely alleviated suggesting possible GON activation by
the block procedure then suppression once the anaesthetic
started to take effect.
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However, one must question how, after a single GON
block, an individual could develop a full-blown cluster
period lasting months as happened in this patient. One
may consider that in this individual the GON was the pri-
mary generator or trigger of the cluster headaches but the
hypothalamus then became secondarily activated leading
to a long-lasting cluster period. A connection exists
between the GON and the hypothalamus via the trigemi-
no-hypothalamic pathway (trigeminocervical-hypothala-
mic connection). Theoretically after the GON was stimu-
lated in this individual the hypothalamus was then secon-
darily activated via this anatomic connection. In this sce-
nario as the hypothalamus was being activated secondari-
ly this could lead to an irregular pattern of hypothalamic
firing and thus an atypical cluster presentation. The fre-
quent side-shifting of attacks suggests that the hypothala-
mus was activated bilaterally (unilaterally at irregular
intervals) instead of the persistent same side activation
noted in typical primary cluster. The patient did undergo
bilateral GON blockade.
The clinical presentation of this case patient suggests
that there can be a non-hypothalamic form of cluster
headache and that the GON may play a significant role in
cluster pathogenesis in some patients. Secondary hypo-
thalamic activation may have been needed to sustain the
syndrome. It is possible that the patient developed sponta-
neous new onset cluster headache at age 53, but the close
temporal profile to the GON procedure and the fact that
only women appear to have a second peak of cluster onset
in their fifties and sixties suggest against this scenario [6].
References
1. May A, Bahra A, Buchel C,
Frackowiak RS, Goadsby PJ (1998)
Hypothalamic activation in cluster
headache attacks. Lancet
352(9124):275–278
2. Sinnamon HM, Karvosky ME, Ilch CP
(1999) Locomotion and head scanning
initiated by hypothalamic stimulation
are inversely related. Behav Brain Res
99(2):219–229
3. Bartsch T, Goadsby PJ (2003) The
trigeminocervical complex and
migraine: current concepts and synthe-
sis. Curr Headache Rep 7(5):371–376
4. Bartsch T, Goadsby PJ (2002)
Stimulation of the greater occipital
nerve induces increased central
excitability of dural afferent input.
Brain 125(7):1496–1509
5. Piovesan EJ, Kowacs PA, Tatsui CE,
Lange MC, Ribas LC, Werneck LC
(2001) Referred pain after painful
stimulation of the greater occipital
nerve in humans: evidence of conver-
gence of cervical afferents on trigemi-
nal nuclei. Cephalalgia 21(2):107–109
6. Rozen TD, Niknam RM, Shechter AL,
Young WB, Silberstein SD (2001)
Cluster headache in women: clinical
characteristics and comparison to clus-
ter headache in men. J Neurol
Neurosurg Psychiatry 70(5):613–617
